1. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire studyResearch in context
- Author
-
Sophie C. Frölke, Pim Bouwmans, A. Lianne Messchendorp, Johanna P.M. Vervoort, Alferso C. Abrahams, Aiko P.J. de Vries, Pythia T. Nieuwkerk, Marc H. Hemmelder, Ron T. Gansevoort, Luuk B. Hilbrands, Marlies E.J. Reinders, Jan-Stephan F. Sanders, Frederike J. Bemelman, Suzanne E. Geerlings, C. Imhof, C. Idzinga, C. Siegert, C.C. Baan, C.J.A.M. Konings, C. van Kessel, D. van Baarle, D.A. Diavatopoulos, D. Standaar, E. ten Hoope, E. Til, E.B.M. Remmerswaal, F. van der Klis, H.R. Fritsen, I. Stijnman, J.N. Brinkman, J. Cheng, L. den Biggelaar, M. ten Dam, M. Steenhuis, M. Zwerink, M.H.J. Braks, M. Willems, M.L. Kho, N. Rots, P. Vart, R.G. van der Molen, R.M.A. van den Dorpel, R.S.R.K. Malaha, R.C.G. ter Meulen, T. Rispens, T. Steenvoorden, T. de Ronde, V.J.P. Peters, W.S. Konijn, W.M.T. Janssen, W.J. Bos, Y.M.R. Adema, and Y. Vegting
- Subjects
Kidney transplantation ,SARS-CoV-2 ,Vaccination ,Behavior ,Adherence ,Medicine (General) ,R5-920 - Abstract
Summary: Background: Kidney transplant recipients (KTRs) were advised to tightly adhere to government recommendations to curb the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) because of a high risk of morbidity and mortality and decreased immunogenicity after vaccination. The aim of this study was to analyse the change in adherence to preventive measures after vaccination and awareness of antibody response, and to evaluate its effectiveness. Methods: In this large-scale, national questionnaire study, questionnaires were sent to 3531 KTRs enrolled in the Dutch RECOVAC studies, retrospectively asking for adherence to nine preventive measures on a 5-point Likert scale before and after SARS-CoV-2 vaccination and after awareness of antibody response. Blood samples were collected 28 days after the second vaccination. Antibody response was categorised as non-responder (≤50 BAU/mL), low-responder (>50 ≤ 300 BAU/mL) or high-responder (>300 BAU/mL), and shared with participants as a correlate of protection. Participants of whom demographics on sex and age, blood samples and completed questionnaires were available, were included. Our study took place between February 2021 and January 2022. The primary outcome of adherence before and after vaccination was assessed between August and October 2021 and compared via the Wilcoxon signed rank sum test. Logistic regression analysis was performed to estimate the association between antibody response and non-adherence, and adherence on acquiring SARS-CoV-2 infection. This study is registered at ClinicalTrials.gov (NCT04841785). Findings: In 2939 KTRs (83%) who completed the first questionnaire on adherence to preventive measures, adherence was higher before than after vaccination (4.56, IQR 4.11–4.78 and 4.22, IQR 3.67–4.67, p
- Published
- 2023
- Full Text
- View/download PDF